Deaths preventable in the U.S. by improvements in use of clinical preventive services.
about
Coronary risk assessment among intermediate risk patients using a clinical and biomarker based algorithm developed and validated in two population cohortsTracking the delivery of prevention-oriented care among primary care providers who have adopted electronic health recordsHeart disease and stroke statistics--2014 update: a report from the American Heart AssociationAdherence to Antihypertensive Therapy.Is prevention a fantasy, or the future of medicine? A panoramic view of recent data, status, and direction in cardiovascular prevention.Developing Methods of Repurposing Electronic Health Record Data for Identification of Older Adults at Risk of Unintentional FallsA framework for smartphone-enabled, patient-generated health data analysisPregnancy: An Underutilized Window of Opportunity to Improve Long-term Maternal and Infant Health-An Appeal for Continuous Family Care and Interdisciplinary Communication.A 16-month community-based intervention to increase aspirin use for primary prevention of cardiovascular disease.Pilot trial of a licensed practical nurse intervention for hypertension and depression.Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey.Identifying patients with hypertension: a case for auditing electronic health record data.Clinical utility of a novel coronary heart disease risk-assessment test to further classify intermediate-risk patientsResistant hypertension and obstructive sleep apnea in the primary-care setting.Preventive service gains from first contact access in the primary care home.Satisfaction with aging and use of preventive health services.The influence of health disparities on targeting cancer prevention efforts.A pathway to leadership for adult immunization: recommendations of the National Vaccine Advisory Committee: approved by the National Vaccine Advisory Committee on June 14, 2011Azilsartan Medoxomil (Edarbi): The Eighth Angiotensin II Receptor Blocker.Aspirin use and cardiovascular events in social networks.Simulating Strategies for Improving Control of Hypertension Among Patients with Usual Source of Care in the United States: The Blood Pressure Control Model.The preventive services use self-efficacy (PRESS) scale in older women: development and psychometric propertiesVaccinations and preventive screening services for older adults: opportunities and challenges in the USA.Number of first-contact access components required to improve preventive service receipt in primary care homes.Increased mortality risk among the visually impaired: the roles of mental well-being and preventive care practicesDrugs for Primary Prevention of Atherosclerotic Cardiovascular Disease: An Overview of Systematic Reviews.Patients with undiagnosed hypertension: hiding in plain sightOn the epigenetics of vascular regulation and diseaseComparison of patients' confidence in office, ambulatory, and home blood pressure measurements as methods of assessing for hypertension.Intelligence in youth and health at age 50.Systematic review of chinese traditional exercise baduanjin modulating the blood lipid metabolismCross-sectional study examining whether the extent of first-contact access to primary care differentially benefits those with certain personalities to receive preventive servicesPopulation Trends in Aspirin Use for Cardiovascular Disease Prevention 1980-2009: The Minnesota Heart SurveyA national evaluation of a dissemination and implementation initiative to enhance primary care practice capacity and improve cardiovascular disease care: the ESCALATES study protocol.Testing the use of practice facilitation in a cluster randomized stepped-wedge design trial to improve adherence to cardiovascular disease prevention guidelines: HealthyHearts NYCSustained improvement in clinical preventive service delivery among independent primary care practices after implementing electronic health record systems.Comparative Effectiveness of Personalized Lifestyle Management Strategies for Cardiovascular Disease Risk Reduction.Hypertension Treatment ACCORDing to SPRINTCombination With Low-dose Dextromethorphan Improves the Effect of Amlodipine Monotherapy in Clinical Hypertension: A First-in-human, Concept-proven, Prospective, Dose-escalation, Multicenter Study.Hypertension Control Cascade: A Framework to Improve Hypertension Awareness, Treatment, and Control.
P2860
Q28686330-11B75D77-D2B9-4452-95E8-DC2A8A772E8CQ28741330-CB3F8075-6FB9-4FB5-8ADE-9E190B6B9BADQ29547691-D2F62641-F8B9-4AC6-B99E-ECAF63BDF4C3Q30240726-187F532E-4AE5-441F-8ECA-48189582F559Q30397875-477BCF73-46A6-485A-81DA-AA7AFBB88650Q31088910-F21E902E-1E27-47CD-824B-E1FF384DCF8CQ31122789-C33C06D2-ADB4-4D2F-A687-A033AD10F1FDQ33559194-0972FB8F-D981-442A-B3C6-BECF27C62EC1Q33622632-481F5A18-CB08-4D99-BE32-145157854C88Q33828063-1902B15C-10DD-458C-82F7-EBDF321046F2Q33972551-11828F04-A028-45DD-8615-E64EFC8A50DAQ34318290-415F8AE4-FBC9-4E1C-82A8-DD846B042489Q34507187-05B25FEF-39B7-45FE-841C-0AC26219878EQ35094595-99DBE14C-4249-43DD-B68C-2E5EF277D64EQ35108022-F9BEE52D-9DF7-428E-90AF-61171BB7695AQ35584745-49A128CC-9778-492C-9AE0-736E156E0A7AQ35606468-B40BCFA2-3242-4F29-AAAC-C41AE213F59FQ35606837-A01633BF-BB87-4817-A70A-EEBA7F5C2E69Q35752825-43E73B1B-8DE0-46A9-BEDE-4500F5CE809BQ35818810-ED7B0395-B9DC-4019-9D2C-78E6945013DAQ35876683-8BBFA261-44DD-4F13-ACB9-9BC226EC17A9Q35929353-18BFC01E-A4B1-4010-8455-E3D3734DBCE0Q35939729-129D16CA-9BC2-4480-AC17-03F45DCC44E6Q35980627-3B2EE117-A8D9-4FBC-8068-C22FCF9865D2Q36006631-BDC6F58E-5563-4A90-8F54-EFB2303189F3Q36082805-B2124FFB-332A-4265-AE69-17CE00EA9105Q36130572-5E3D6FEA-8468-4744-8DD2-C185A08A3C2CQ36222404-3F60E1BE-8028-4224-B27D-56B56977B85DQ36244929-B51FAB40-7177-4410-AAC6-340FD687771FQ36318488-9F368DD8-9FA6-44B5-BCE4-528A1EED69B2Q36473568-8243CA84-AFE8-4CBE-A27E-0B9CFFE141DFQ36670590-A62AFCE1-45C5-472C-89CC-4D81D24F4392Q36836426-5C3F3976-B0E2-42E5-91DD-1C9A5BFCFACAQ37054931-79E24F32-5834-4D4E-BB49-E117D4BFC13FQ37064352-34DC2963-C4DF-4604-9066-A4E28E42E13DQ37070262-92C7F061-ABCD-4B64-934A-D687F4C50155Q37090741-DD141817-4C34-43A2-AD53-94CDF3DDEC26Q37164180-4409D340-BB40-4520-AEF1-19AEBB83C5FDQ37205504-5D1C194D-FB1F-40BE-8231-9D44032600B5Q37309028-57B883D1-6931-4C94-8E47-FE82B25497C9
P2860
Deaths preventable in the U.S. by improvements in use of clinical preventive services.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Deaths preventable in the U.S. by improvements in use of clinical preventive services.
@ast
Deaths preventable in the U.S. by improvements in use of clinical preventive services.
@en
Deaths preventable in the U.S. by improvements in use of clinical preventive services.
@nl
type
label
Deaths preventable in the U.S. by improvements in use of clinical preventive services.
@ast
Deaths preventable in the U.S. by improvements in use of clinical preventive services.
@en
Deaths preventable in the U.S. by improvements in use of clinical preventive services.
@nl
prefLabel
Deaths preventable in the U.S. by improvements in use of clinical preventive services.
@ast
Deaths preventable in the U.S. by improvements in use of clinical preventive services.
@en
Deaths preventable in the U.S. by improvements in use of clinical preventive services.
@nl
P1476
Deaths preventable in the U.S. by improvements in use of clinical preventive services.
@en
P2093
Mehul A Dalal
Thomas A Farley
P304
P356
10.1016/J.AMEPRE.2010.02.016
P577
2010-06-01T00:00:00Z